CG′806, a First-in-Class FLT3/BTK Inhibitor, Exerts Superior Potency against AML Cells Harboring ITD, TKD and Gatekeeper Mutated FLT3 or Wild-Type FLT3

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2017-09, Vol.17, p.S274-S275
Main Authors: Zhang, Weiguo, Zhang, Hongying, Local, Andrea, Rice, Wiliam, Ly, Charlie, Yu, Guopan, Howell, Stephen, Andreeff, Michael
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
2152-2669
DOI:10.1016/j.clml.2017.07.051